Press releases

  21/12/2017 18:00
|

Quantum Genomics to Present at Biotech Showcase 2018

  15/11/2017 07:30
|

Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

  27/10/2017 07:30
|

Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

  16/10/2017 18:00
|

Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

  03/10/2017 18:15
|

Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

  07/09/2017 18:00
|

Quantum Genomics to Present at Rodman and Renshaw 19th Annual Global Investment Conference

  05/09/2017 18:00
|

Quantum Genomics Receives FDA Clearance of IND Application for QGC001

  26/07/2017 08:45
|

Quantum Genomics raises EUR 8.2 Million in Europe and the U.S.

  11/07/2017 07:30
|

Quantum Genomics begins trading in the U.S. on OTCQX

  30/06/2017 07:30
|

Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board

  28/06/2017 07:30
|

Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE

  19/06/2017 07:30
|

Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

  07/06/2017 18:20
|

Quantum Genomics to host two upcoming events

  23/05/2017 18:00
|

Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States

  09/05/2017 18:00
|

Quantum Genomics will organize a teleconference on June 19, 2017, to comment on phase IIa data in high blood pressure

  25/04/2017 18:00
|

Quantum Genomics appoints Bruno Besse as Chief Medical Officer

  30/03/2017 18:00
|

2016 annual financial results and next development steps in 2017

  14/03/2017 18:00
|

Quantum Genomics announces positive data from new preclinical studies with QGC001

  20/02/2017 18:00
|

2017 financial calendar - Quantum Genomics has joined the Pass French Tech program

  02/02/2017 18:00
|

Quantum Genomics granted key European patent for QGC011 combination therapy program